These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24097168)

  • 21. Amiodarone: clinical trials.
    Naccarelli GV; Wolbrette DL; Patel HM; Luck JC
    Curr Opin Cardiol; 2000 Jan; 15(1):64-72. PubMed ID: 10666663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventricular tachycardia converts to sinus rhythm after administration of propofol.
    Shannon K; Saltzman D; Li I; Mokszycki R; Galletta G
    Am J Emerg Med; 2021 Oct; 48():377.e1-377.e3. PubMed ID: 33875319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current concepts in electrical defibrillation.
    Truong JH; Rosen P
    J Emerg Med; 1997; 15(3):331-8. PubMed ID: 9258783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MY APPROACH to the patient with ventricular arrhythmia and no structural heart disease.
    Issa ZF
    Trends Cardiovasc Med; 2019 Apr; 29(3):190. PubMed ID: 30814035
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study.
    Greene HL
    Am Heart J; 1994 Apr; 127(4 Pt 2):1171-8. PubMed ID: 8160597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.
    Pokorney SD; Mi X; Hammill BG; Allen LaPointe NM; Curtis LH; Al-Khatib SM
    Am J Cardiol; 2017 May; 119(9):1401-1406. PubMed ID: 28341360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External implantable defibrillator as a bridge to reimplant after implantable cardioverter-defibrillator explant.
    Dell'Era G; Magnani A; Occhetta E
    Europace; 2015 Nov; 17(11):1726. PubMed ID: 26462698
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
    Böcker D; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 30. [Implanted automatic defibrillator after ventricular fibrillation treated with semi-automatic defibrillation].
    Ould-Ahmed M; Bordier E; Leenhardt A; Frank R; Michel A
    Ann Fr Anesth Reanim; 1998; 17(1):47-51. PubMed ID: 9750683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transvenous biventricular defibrillation can improve defibrillation threshold.
    Snow JS; Larsen A; Cohen TJ
    Pacing Clin Electrophysiol; 2004 Sep; 27(9):1327-8. PubMed ID: 15461729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QT dispersion significantly increases after implantable cardioverter-defibrillator shocks.
    Topaloglu S; Aras D; Sahin O; Ergun K; Deveci B; Ozdemir O; Ozeke O; Yildiz A; Alyan O; Demir AD; Soylu M; Kisacik HL; Korkmaz S
    Ann Noninvasive Electrocardiol; 2007 Jan; 12(1):44-9. PubMed ID: 17286650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic Review and Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Therapy in Patients With Chagas Heart Disease.
    Rassi FM; Minohara L; Rassi A; Correia LCL; Marin-Neto JA; Rassi A; da Silva Menezes A
    JACC Clin Electrophysiol; 2019 Oct; 5(10):1213-1223. PubMed ID: 31648747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Implantable cardioverter defibrillator does not eliminate need for antiarrhythmic drugs in secondary prevention of life threatening ventricular arrhythmias. Results of OPTIC trial].
    Iavelov IS
    Kardiologiia; 2006; 46(3):74-5. PubMed ID: 16710262
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
    Farré J; Cabrera JA; Romero J; Rubio JM
    Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials of implantable defibrillators.
    Myerburg RJ; Castellanos A
    N Engl J Med; 1997 Nov; 337(22):1621-3. PubMed ID: 9371860
    [No Abstract]   [Full Text] [Related]  

  • 38. Challenges in cardiac resynchronization therapy-defibrillator upgrade in a patient with right pneumonectomy.
    Chow J; Kam R
    Europace; 2012 Oct; 14(10):1497. PubMed ID: 22581652
    [No Abstract]   [Full Text] [Related]  

  • 39. Do we need a randomized trial of defibrillator therapy in every subset of patients with increased risk of sudden death?
    Exner DV; Klein GJ
    J Cardiovasc Electrophysiol; 2003 Jun; 14(6):574-7. PubMed ID: 12875415
    [No Abstract]   [Full Text] [Related]  

  • 40. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R; Cinca J; Marber M
    Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.